Skip to main content

Table 3 The relationships between microRNA-143 expression and clinical features of patients in the restenosis and non-restenosis groups

From: Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease

Feature Restenosis group (n = 74) Non-restenosis group (n = 91)
N Relative expression t P N Relative expression t P
Age (years)
 <60 40 0.53 ± 0.07 1.39 0.169 49 0.64 ± 0.14 0.64 0.526
 ≥60 34 0.51 ± 0.05 42 0.62 ± 0.16
Smoking
 Yes 59 0.50 ± 0.04 7.75 <0.001 27 0.62 ± 0.14 0.28 0.779
 No 15 0.60 ± 0.06 64 0.63 ± 0.16
Diabetes
 Yes 21 0.48 ± 0.04 3.51 0.001 6 0.62 ± 0.20 0.16 0.878
 No 53 0.53 ± 0.06 85 0.63 ± 0.15
Blood sugar
 High 14 0.45 ± 0.04 6.27 <0.001 19 0.60 ± 0.12 1.11 0.313
 Low 60 0.54 ± 0.05 72 0.64 ± 0.16
LDL-C
 >2.6 mmol/L 35 0.49 ± 0.06 5.11 <0.001 20 0.61 ± 0.12 0.78 0.439
 ≤2.6 mmol/L 39 0.55 ± 0.04 71 0.64 ± 0.1
Hyperlipidemia
 Yes 15 0.51 ± 0.04 0.61 0.544 17 0.64 ± 0.15 0.74 0.459
 No 59 0.52 ± 0.06 74 0.63 ± 015
  1. LDL-C low-density lipoprotein cholesterol